Body One (XPAR:MLONE) Research & Development: €0.00 Mil (TTM As of Dec. 2024)


What is Body One Research & Development?

Body One XPAR:MLONE Research & Development is €0.00 Mil as of Dec. 2024. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Body One's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Body One  (XPAR:MLONE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Body One Research & Development Related Terms

Body One Research & Development Historical Data

* Premium members only.

The historical data trend for Body One's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Body One Research & Development Chart

Body One Annual Data
Trend Mar15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Body One Semi-Annual Data
Mar15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec24
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Body One Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Body One (XPAR:MLONE) has a Research & Development of €0.00 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Body One and its competitors.
Is Body One's Research & Development too high?
Body One's current Research & Development is €0.00 Mil.
How does Body One's Research & Development compare to RL and LEVI?
Body One's Research & Development of €0.00 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Manufacturing - Apparel & Accessories company?
A good Research & Development depends on the Manufacturing - Apparel & Accessories industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Body One and its competitors. Body One's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Body One stock overvalued right now?
Based on GuruFocus' analysis, Body One (XPAR:MLONE) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.35, compared to a current price of €0.88 — trading 151.4% above its estimated fair value. The current Research & Development is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Body One (XPAR:MLONE), the current Research & Development is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Body One Business Description

Address 47-49 rue Cartier Bresson, Pantin, FRA, 93500
Body One SA manufactures and sells lingerie for women. The company product portfolio includes nightwear lingerie, swimwear lingerie, and sportswear lingerie.